scispace - formally typeset
G

Galo L. Mejia

Researcher at University of Texas at Dallas

Publications -  23
Citations -  574

Galo L. Mejia is an academic researcher from University of Texas at Dallas. The author has contributed to research in topics: Neuropathic pain & AMPK. The author has an hindex of 12, co-authored 21 publications receiving 377 citations. Previous affiliations of Galo L. Mejia include University of Arizona.

Papers
More filters
Journal ArticleDOI

Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice

TL;DR: It is shown that the TMEM97 gene is expressed in mouse and human dorsal root ganglion including populations of neurons that are involved in pain; however, the gene is also likely expressed in non-neuronal cells that may contribute to the observed behavioral effects.
Journal ArticleDOI

Mycobacterium tuberculosis Sulfolipid-1 Activates Nociceptive Neurons and Induces Cough

TL;DR: It is shown that an Mtb organic extract activates nociceptive neurons in vitro and the Mtb glycolipid sulfolipid-1 (SL-1) as the nocICEptive molecule and Mtb-infected guinea pigs cough in a manner dependent on SL-1 synthesis.
Journal ArticleDOI

Neuropathic Pain Creates an Enduring Prefrontal Cortex Dysfunction Corrected by the Type II Diabetic Drug Metformin But Not by Gabapentin.

TL;DR: A neuropathic pain model in mice is used to demonstrate that male (but not female) mice show a robust pain-related deficit in attentional set-shifting, which is associated with structural plasticity in axon initial segments in the infralimbic cortex.
Journal ArticleDOI

Spinal Inhibition of P2XR or p38 Signaling Disrupts Hyperalgesic Priming in Male, but not Female, Mice.

TL;DR: This work is consistent with previous findings that P2XR and p38 inhibition can lead to male-specific effects on pain behaviors in mice, however, given that microglial activation at time points where these drugs were effective, it is questioned whether these effects can be completely attributed to microglia.